144 ·Filed May 22, 2026

GH

Guardant Health, Inc.
BEARISH
Impact 5/10
Horizondays Processed3mo ago SEC0001921094-26-000542
Form 144 — notice of proposed sale of securities
Actionable Insight ▼ Bearish

The filing signals that a former affiliate has considered monetizing a significant equity position. While the sale is not guaranteed, the size relative to recent insider activity ($4.7M in total sells over 30 days) is notable. Monitor for actual Form 4 filings to confirm execution, and watch for any additional insider selling patterns ahead of the next earnings report.

DirectionBearish
Confidencemedium
Horizondays
Final — all horizons settled through T+60d
GH ▲ +36.16% at T+60d
SHORT call ✗ call lost -36.16% · α vs SPY -33.70% · entry $119.29 → $162.43
Entry anchored
May 22, 03:59 PM ET
via exchange tick
T+1d
+6.84%
call -6.84% · α -6.83%
$127.45
settled 4mo ago
T+5d
+9.09%
call -9.09% · α -7.87%
$130.13
settled 4mo ago
T+20d
+9.67%
call -9.67% · α -11.94%
$130.83
settled 3mo ago
T+60d
+36.16%
call -36.16% · α -33.70%
$162.43
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Craig Eagle, a former affiliate of Guardant Health, filed a Form 144 notice of intent to sell 160,817 shares of common stock, with an approximate market value of $19.1 million based on the filing date. This represents a material insider sale by a former affiliate, though the filing notes the shares may be sold over various dates and the sale may not occur.

Key Facts

  • Craig Eagle, a former affiliate of Guardant Health, filed a Form 144 on May 22, 2026.
  • The proposed sale covers 160,817 shares of common stock.
  • Approximate market value of the proposed sale is $19,091,422 based on the filing date.
  • The shares are being sold through Charles Schwab & Co., Inc.
  • The nature of the acquisition is an employee stock option exercise, with the sale described as a 'Broker Payment for Cashless Exercise'.
  • The filing states the shares may be sold over various dates, indicating the sale is not immediate or guaranteed.

Financial Impact

Proposed sale of 160,817 shares valued at approximately $19.1 million, representing about 0.12% of the company's $17.6B market cap.

dilutioninsider ownership

Risk Factors

  • Insider selling may signal lack of confidence or upcoming negative catalyst.
  • The sale is not guaranteed; the insider may choose not to execute.
  • Additional insider selling could follow, increasing selling pressure.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
91% bullish (32 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001921094-26-000542
Document: 0001921094-26-000542-index.html0001921094-26-000542
Document: 0001921094-26-000542.txt0001921094-26-000542
26 reports for GH
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+60▲ +31.56%May 27, 2026
Filters
Rows
Reports for GH — sortable, filterable
TypeNow
Aug 24, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$163.18 $177.16▲ +8.57%▲ +7.25%$177.80 (+8.96%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$157.21 $167.84▲ +6.76%▲ +8.75%$177.80 (+13.10%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$157.21 $167.84▲ +6.76%▲ +8.75%$177.80 (+13.10%)
Aug 11, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$165.11 $159.03▼ −3.68%▼ −1.78%$177.80 (+7.69%)
Aug 11, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$165.11 $159.03▼ −3.68%▼ −1.78%$177.80 (+7.69%)
Aug 6, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$168.48 $161.41▼ −4.20%▼ −3.80%$177.80 (+5.53%)
Jul 30, 2026
9w ago
S-3ASR
NEUTRAL ★ 2/10
$161.99 $161.49▼ −0.31%▼ −3.29%$177.80 (+9.76%)
Jun 30, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$170.77 $144.07▼ −15.64%▼ −13.45%$177.80 (+4.12%)
Jun 22, 2026
14w ago
144
NEUTRAL ★ 2/10
$130.83 $148.07▲ +13.18%▲ +12.02%$177.80 (+35.90%)
Jun 16, 2026
15w ago
Court Ruling
BEARISH ★ 7/10
$127.34 $160.11▼ −25.73%▼ −25.53%$177.80 (−39.63%)
Showing 10 of 26

US Market Status

Market Closed — Opens Mon (64h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access